Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Zonulin is a human protein that regulates the permeability of tight junctions between cells in the intestinal epithelium. It is the only known physiological modulator capable of reversibly controlling intestinal permeability. Elevated zonulin levels are associated with increased intestinal permeability and autoimmune diseases. It is considered a therapeutic target for diseases involving increased intestinal permeability.
Zonulin inhibitors reduce intestinal permeability by preventing zonulin-mediated tight junction disassembly.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Zonulin (None).